Skip to main content

ACR Convergence 2022 Main banner

Schedule at a Glance

Community Hub

Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)

Format: Virtual Only

521: CH Myositis: Myopathy: Issues in Diagnosis and Treatment Viewpoint

Saturday, November 12, 2022

1:00 PM – 1:30 PM Eastern Time

All of the relevant financial relationships listed for faculty have been mitigated.

Community Speaker(s)

CO

Chester Oddis, MD

University of Pittsburgh
Pittsburgh, PA, United States

Disclosure(s): CSL Behring: Grant/Research Support (Ongoing); EMD Serono: Grant/Research Support (Ongoing)

Hub Host(s)

Rohit Aggarwal, MD, MS

University of Pittsburgh
Pittsburgh, PA, United States

Disclosure(s): AbbVie: Consultant (Ongoing); Alexion: Consultant (Ongoing); Argenx: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Boehringer Ingelheim: Consultant (Ongoing); Bristol Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); Corbus: Consultant (Ongoing); CSL Behring: Consultant (Ongoing); EMD Serono: Consultant (Ongoing), Grant/Research Support (Ongoing); Genentech: Grant/Research Support (Ongoing); Janssen: Consultant (Ongoing); Jubilant: Consultant (Ongoing); Kezar: Consultant (Ongoing); Kyverna: Consultant (Ongoing); Mallinckrodt: Consultant (Ongoing), Grant/Research Support (Ongoing); Octapharma: Consultant (Ongoing); Orphazyme: Consultant (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Q32: Consultant (Ongoing), Grant/Research Support (Ongoing); Roivant: Consultant (Ongoing)
Julie Paik, MD, MHS

Johns Hopkins University
Baltimore, MD, United States

Disclosure(s): Alexion Inc: Consultant (Ongoing), Grant/Research Support (Ongoing); Argenx: Consultant (Ongoing); Kezar Inc: Consultant (Ongoing); Pfizer Inc: Consultant (Ongoing), Grant/Research Support (Ongoing); Roivant: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing)